Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Johnson and Johnson
Dow
Moodys
McKesson

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2017)


Email this page to a colleague

« Back to Dashboard

Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2017)

Docket ⤷  Try it Free Date Filed 2017-04-07
Court District Court, D. Delaware Date Terminated 2020-07-28
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties INTELLIPHARMACEUTICS CORPORATION
Patents 8,309,060; 9,060,976; 9,073,933; 9,492,389; 9,492,391; 9,522,919
Attorneys Shashank D. Upadhye
Firms Smith, Katzenstein, & Jenkins LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Purdue Pharma L.P. v. Intellipharmaceutics International Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , and ⤷  Try it Free .

Details for Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2018-05-31 123 Notice of Service . Wuts, Ph.D. on the Invalidity of U.S. Patents Nos. 9,073,933 B2 and 9,522,919 B2 filed by Intellipharmaceutics…2017 28 July 2020 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
2018-06-11 126 Notice of Service , Ph.D. on the Non-Infringement of U.S. Patent Nos. 9,073,933 B2 and 9,522,919 B2 filed by Intellipharmaceutics…Non-Infringement of the Asserted Claims of the '993 and '919 Patents and Supplemental Expert Report of Neil E. Spingarn…Invalidity of the Asserted Claims of the '993 and '919 Patents; and (4) Rebuttal Expert Report of Peter G.M. Wuts…2017 28 July 2020 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
2018-07-06 130 Opinion - Memorandum Opinion of multiple terms in U.S. Patent Nos. 9,060,976 ("the '976 patent"), 9,073 ,933 ("…construction for multiple terms in U.S. Patent Nos. 9,060,976, 9,073,933, 9,522,919, 9,492,389, and 9,…quot;the ' 933 patent"), 9,522,919 ("the ' 919 patent"), 9,492,389 ("the &… ' 389 patent"), and 9,492,391 ("the '391 patent"). The Court has considered…would infringe six of Plaintiffs' patents. (D.I. 1). The patents-in-suit relate to OxyContin®, an extended-release External link to document
2018-08-03 144 Notice of Service , Ph.D. on the Non-Infringement of U.S. Patent Nos. 9,060,976; 9,492,389; 9,492,391 filed by Intellipharmaceutics…2017 28 July 2020 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
2019-07-19 204 Notice of Service Ph.D., on the Non-Infringement of U.S. Pat. Nos. 9,060,976; 9,492,389 filed by Intellipharmaceutics Corporation…2017 28 July 2020 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
2019-07-22 205 Notice of Service , Ph.D. on the Non-Infringement of U.S. Patent Nos. 9,073,933 B2 and 9,522,919 B2 filed by Intellipharmaceutics…2017 28 July 2020 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
2020-07-29 240 Patent/Trademark Report to Commissioner of Patents ,073,933; 9,522,919; 9,492,389; 9,492,391; 8,309,060. (Attachments: # 1 Order)(nms) (Entered: 07/29/2020… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,060,976; 9,073,933…2017 28 July 2020 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Express Scripts
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.